These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2205405)

  • 21. Synthesis of para-benzoquinone and 1,3-bis(2-chloroethyl)nitrosourea adducts and their incorporation into oligonucleotides.
    Chenna A; Maruenda H; Singer B
    IARC Sci Publ; 1999; (150):89-101. PubMed ID: 10626211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluoranthene-DNA adducts: identification and quantification by an HPLC-32P-postlabeling method.
    Gorelick NJ; Wogan GN
    Carcinogenesis; 1989 Sep; 10(9):1567-77. PubMed ID: 2670301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new sensitive 32P-postlabeling assay based on the specific enzymatic conversion of bulky DNA lesions to radiolabeled dinucleotides and nucleoside 5'-monophosphates.
    Randerath K; Randerath E; Danna TF; van Golen L; Putman KL
    Carcinogenesis; 1989 Jul; 10(7):1231-9. PubMed ID: 2544310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Commentary on 'Formation of Deoxycytidine 5'-Phosphate from Cytidine 5'-Phosphate with Enzymes from Escherichia coli'.
    Reichard P
    Biochim Biophys Acta; 1989; 1000():49-50. PubMed ID: 2673404
    [No Abstract]   [Full Text] [Related]  

  • 25. 32P-postlabeling analysis of DNA adducts formed by leukotriene A4 (LTA4).
    Funk D; Sorg BL; Lindner SC; Schmeiser HH
    Environ Mol Mutagen; 2010 May; 51(4):338-43. PubMed ID: 20120015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of DNA adducts derived from riddelliine, a carcinogenic pyrrolizidine alkaloid.
    Chou MW; Jian Y; Williams LD; Xia Q; Churchwell M; Doerge DR; Fu PP
    Chem Res Toxicol; 2003 Sep; 16(9):1130-7. PubMed ID: 12971801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formation of reactive metabolites from benzene.
    Snyder R; Jowa L; Witz G; Kalf G; Rushmore T
    Arch Toxicol; 1987; 60(1-3):61-4. PubMed ID: 3619644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 32P-postlabeling analysis of adducts formed from 1-phenylazo-2-hydroxynaphthalene (Sudan I, Solvent Yellow 14) with DNA and homopolydeoxyribonucleotides.
    Stiborová M; Frei E; Schmeiser HH; Wiessler M
    Carcinogenesis; 1992 Jul; 13(7):1221-5. PubMed ID: 1638690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of styrene oxide-DNA adducts by 32P-postlabeling.
    Liu SF; Rappaport SM; Rasmussen J; Bodell WJ
    Carcinogenesis; 1988 Aug; 9(8):1401-4. PubMed ID: 3402036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure, conformations, and repair of DNA adducts from dibenzo[a, l]pyrene: 32P-postlabeling and fluorescence studies.
    Jankowiak R; Ariese F; Hewer A; Luch A; Zamzow D; Hughes NC; Phillips D; Seidel A; Platt KL; Oesch F; Small GJ
    Chem Res Toxicol; 1998 Jun; 11(6):674-85. PubMed ID: 9625736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of 32P-postlabeling analysis of DNA from exfoliated oral mucosa cells as a means of monitoring exposure of the oral cavity to genotoxic agents.
    Foiles PG; Miglietta LM; Quart AM; Quart E; Kabat GC; Hecht SS
    Carcinogenesis; 1989 Aug; 10(8):1429-34. PubMed ID: 2502322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclease S1-mediated enhancement of the 32P-postlabeling assay for aromatic carcinogen-DNA adducts.
    Reddy MV
    Carcinogenesis; 1991 Sep; 12(9):1745-8. PubMed ID: 1893535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postlabeling methods for carcinogen-DNA adduct analysis.
    Randerath K; Randerath E; Agrawal HP; Gupta RC; Schurdak ME; Reddy MV
    Environ Health Perspect; 1985 Oct; 62():57-65. PubMed ID: 3910421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tamoxifen-DNA adduct formation in rat liver determined by immunoassay and 32P-postlabeling.
    Divi RL; Osborne MR; Hewer A; Phillips DH; Poirier MC
    Cancer Res; 1999 Oct; 59(19):4829-33. PubMed ID: 10519392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 32-P-HPLC analysis of DNA adducts formed in vitro and in vivo by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline, utilizing an improved adduct enrichment procedure.
    Wohlin P; Zeisig M; Gustafsson JA; Möller L
    Chem Res Toxicol; 1996 Sep; 9(6):1050-6. PubMed ID: 8870995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and 32P-postlabeling/high-performance liquid chromatography separation of diastereomeric 1,N2-(1,3-propano)-2'-deoxyguanosine 3'-phosphate adducts formed from 4-hydroxy-2-nonenal.
    Yi P; Zhan D; Samokyszyn VM; Doerge DR; Fu PP
    Chem Res Toxicol; 1997 Nov; 10(11):1259-65. PubMed ID: 9403180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cyclophosphamide/DNA phosphoester adduct formed in vitro and in vivo.
    Maccubbin AE; Caballes L; Riordan JM; Huang DH; Gurtoo HL
    Cancer Res; 1991 Feb; 51(3):886-92. PubMed ID: 1988129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotoxicity of the benzene metabolites para-benzoquinone and hydroquinone.
    Gaskell M; McLuckie KI; Farmer PB
    Chem Biol Interact; 2005 May; 153-154():267-70. PubMed ID: 15935826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of benzoquinone- and hydroquinone-derivatives of lower chlorinated biphenyls with DNA and nucleotides in vitro.
    Arif JM; Lehmler HJ; Robertson LW; Gupta RC
    Chem Biol Interact; 2003 Jan; 142(3):307-16. PubMed ID: 12453668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentiation of DNA adduct formation in HL-60 cells by combinations of benzene metabolites.
    Lévay G; Bodell WJ
    Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7105-9. PubMed ID: 1496006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.